Viewing Study NCT01088620


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-01-28 @ 5:23 PM
Study NCT ID: NCT01088620
Status: SUSPENDED
Last Update Posted: 2013-03-14
First Post: 2010-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None Stage IIIb or IV View
None Nonsquamous View
None KRAS-Wildtype View